Advanced Search

Study Preview



Study Title and Description

Attenuation of glycemic responses by oat _x001A_-glucan solutions and viscoelastic gels is dependent on molecular weight distribution.



Key Questions Addressed
1 Is this an intervention study?
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Attenuation of glycemic responses by oat _x001A_-glucan solutions and viscoelastic gels is dependent on molecular weight distribution.
Author Kwong MG., Wolever TM., Brummer Y., Tosh SM.
Country Department of Nutritional Sciences, University of Toronto, Toronto, ON, Canada.
Year 2013
Numbers Pubmed ID: 23187607

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Fiber 4.1
Arms
No arms have been defined in this extraction form.

Design Details
Question... Follow Up Answer Follow-up Answer
pubyear 2013
  • Comments Comments (
    0
    ) |
country Canada
  • Comments Comments (
    0
    ) |
design Randomized Controlled Trial (Crossover)
  • Comments Comments (
    0
    ) |
blindness Unspecified
  • Comments Comments (
    0
    ) |
diet Acute Feeding Study
  • Comments Comments (
    0
    ) |
feedcontrol Food partially provided
  • Comments Comments (
    0
    ) |
sampsize 15
  • Comments Comments (
    0
    ) |
runin No
  • Comments Comments (
    0
    ) |
washout No
  • Comments Comments (
    0
    ) |
dosechange No
  • Comments Comments (
    0
    ) |
age_adult 1
  • Comments Comments (
    0
    ) |
age_adol
  • Comments Comments (
    0
    ) |
age_child
  • Comments Comments (
    0
    ) |
age_baby
  • Comments Comments (
    0
    ) |
age_infant
  • Comments Comments (
    0
    ) |
age_oth
  • Comments Comments (
    0
    ) |
age_mean 37.2
  • Comments Comments (
    0
    ) |
age_range
  • Comments Comments (
    0
    ) |
bmi_mean 26.6
  • Comments Comments (
    0
    ) |
bmi_range
  • Comments Comments (
    0
    ) |
blhealth_healthy 1
  • Comments Comments (
    0
    ) |
blhealth_hyperlip
  • Comments Comments (
    0
    ) |
blhealth_diab
  • Comments Comments (
    0
    ) |
blhealth_hyperten
  • Comments Comments (
    0
    ) |
blhealth_digest
  • Comments Comments (
    0
    ) |
blhealth_met
  • Comments Comments (
    0
    ) |
blhealth_oth
  • Comments Comments (
    0
    ) |
blhealth_othspec
  • Comments Comments (
    0
    ) |
gender ~53.33
  • Comments Comments (
    0
    ) |
ftype1 Beta-Glucans
  • Comments Comments (
    0
    ) |
descrip1_1
  • Comments Comments (
    0
    ) |
descrip1_2
  • Comments Comments (
    0
    ) |
dose1_1 4.0
  • Comments Comments (
    0
    ) |
dose1_2
  • Comments Comments (
    0
    ) |
duration1 2 hours
  • Comments Comments (
    0
    ) |
admin1 Beverage
  • Comments Comments (
    0
    ) |
ftype2 Beta-Glucans
  • Comments Comments (
    0
    ) |
descrip2_1
  • Comments Comments (
    0
    ) |
descrip2_2
  • Comments Comments (
    0
    ) |
dose2_1 4.0
  • Comments Comments (
    0
    ) |
dose2_2
  • Comments Comments (
    0
    ) |
duration2 2 hours
  • Comments Comments (
    0
    ) |
admin2 Beverage
  • Comments Comments (
    0
    ) |
ftype3 Beta-Glucans
  • Comments Comments (
    0
    ) |
descrip3_1 High MW _x001A_-glucan containing 50 g anhydrous dextrose
  • Comments Comments (
    0
    ) |
descrip3_2 Low MW _x001A_-glucan containing 50 g anhydrous dextrose
  • Comments Comments (
    0
    ) |
dose3_1 3.0
  • Comments Comments (
    0
    ) |
dose3_2 1.0
  • Comments Comments (
    0
    ) |
duration3 2 hours
  • Comments Comments (
    0
    ) |
admin3 Beverage
  • Comments Comments (
    0
    ) |
ftype4 Beta-Glucans
  • Comments Comments (
    0
    ) |
descrip4_1 low MW _x001A_-glucan containing 50 g anhydrous dextrose
  • Comments Comments (
    0
    ) |
descrip4_2 high MW _x001A_-glucan, containing 50 g of anhydrous dextrose
  • Comments Comments (
    0
    ) |
dose4_1 2.0
  • Comments Comments (
    0
    ) |
dose4_2 2.0
  • Comments Comments (
    0
    ) |
duration4 2 hours
  • Comments Comments (
    0
    ) |
admin4 Beverage
  • Comments Comments (
    0
    ) |
comparator1 matched
  • Comments Comments (
    0
    ) |
cdose1 0.0
  • Comments Comments (
    0
    ) |
cduration1 2 hours
  • Comments Comments (
    0
    ) |
cadmin1 Beverage
  • Comments Comments (
    0
    ) |
comparator2
  • Comments Comments (
    0
    ) |
cdose2
  • Comments Comments (
    0
    ) |
cduration2
  • Comments Comments (
    0
    ) |
cadmin2
  • Comments Comments (
    0
    ) |
comparator3
  • Comments Comments (
    0
    ) |
cdose3
  • Comments Comments (
    0
    ) |
cduration3
  • Comments Comments (
    0
    ) |
cadmin3
  • Comments Comments (
    0
    ) |
comparator4
  • Comments Comments (
    0
    ) |
cdose4
  • Comments Comments (
    0
    ) |
cduration4
  • Comments Comments (
    0
    ) |
cadmin4
  • Comments Comments (
    0
    ) |


Baseline Characteristics
No baseline characteristics have been defined for this extraction form.



Results & Comparisons

No Results found.
Adverse Events
Arm or Total Title Description Comments

Quality Dimensions
No quality dimensions were specified.

Quality Rating
No quality rating data was found.